Yonsei Med J.  2011 Sep;52(5):869-870. 10.3349/ymj.2011.52.5.869.

RE: Pulmonary Hypertension Associated with Use of Phentermine?

• Hendricks
• Rothman RB

• KMID: 1108085
• DOI: http://doi.org/10.3349/ymj.2011.52.5.869

Abstract

No abstract available.

MeSH Terms

Female
Humans
Hypertension, Pulmonary/*drug therapy/*etiology
Phentermine/*adverse effects/*therapeutic use

Reference

1. Bang WD, Kim JY, Yu HT, Cho SS, Jang JY, Oh CM, et al. Pulmonary hypertension associated with use of phentermine. Yonsei Med J. 2010. 51:971–973.

2. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, et al. International Primary Pulmonary Hypertension Study Group. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 1996. 335:609–616.

3. Rich S, Rubin L, Walker AM, Schneeweiss S, Abenhaim L. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. Chest. 2000. 117:870–874.

4. Hendricks EJ, Rothman RB, Greenway FL. How physician obesity specialists use drugs to treat obesity. Obesity (Silver Spring). 2009. 17:1730–1735.

5. Frank A. The long-term management of obesity with continuing pharmacotherapy. Obes Res. 2004. 12:1821–1827.

6. Douglas A, Douglas JG, Robertson CE, Munro JF. Plasma phentermine levels, weight loss and side-effects. Int J Obes. 1983. 7:591–595.

7. Haddock CK, Poston WS, Foreyt JP, DiBartolomeo JJ, Warner PO. Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation. Eat Weight Disord. 2008. 13:95–101.

8. Hendricks EJ, Greenway FL. A study of abrupt phentermine cessation in patients in a weight management program. Am J Ther. 2011. 18:292–299.

9. Rothman RB. Treatment of obesity with "combination" pharmacotherapy. Am J Ther. 2010. 17:596–603.

10. MacLean MR, Dempsie Y. Serotonin and pulmonary hypertension--from bench to bedside? Curr Opin Pharmacol. 2009. 9:281–286.

11. Rothman RB, Cadet JL, Dersch CM, McCoy MT, Lehrmann E, Becker KG, et al. Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension. PLoS One. 2011. 6:e17735.

12. Rothman RB, Baumann MH. Methamphetamine and idiopathic pulmonary arterial hypertension: role of the serotonin transporter. Chest. 2007. 132:1412–1413.

13. Zolkowska D, Rothman RB, Baumann MH. Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease. J Pharmacol Exp Ther. 2006. 318:604–610.